HCCS
protein-codingholocytochrome c synthase, the group of Mitochondrial respiratory chain complex assembly factors
Gene summary
The protein encoded by this gene is an enzyme that covalently links a heme group to the apoprotein of cytochrome c. Defects in this gene are a cause of microphthalmia syndromic type 7 (MCOPS7). Three transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2010]
- MLS
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0024552
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0024552
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0024552
Submitter: PanelApp Australia
Inheritance Pattern: XL
Disease ID:MONDO:0010672
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Cardiovascular; Dermatologic; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Audiologic/Otolaryngologic; Cardiovascular
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; As individuals have been described with a variety of cardiovascular anomalies, surveillance (eg, with echocardiogram/electrocardiogram) may allow detection and early management of related manifestations
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to HCCS variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005333.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 18 | 6 | 29 | ||
| missense | 1 | 2 | 50 | 16 | 2 | 71 |
| nonsense | 1 | 3 | 5 | 9 | ||
| start loss | 1 | 1 | 2 | |||
| frameshift | 2 | 2 | 4 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 7 | 9 | ||
| Total | 4 | 9 | 69 | 34 | 8 | 124 |
Highest pathogenic variant AF is 9.20545e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005324.3 | 6 | MANE Select | |
| Ensembl | ENSP00000370139.4 | 6 | MANE Select | |
| RefSeq | NP_001116080.1 | 6 | Standard | |
| RefSeq | NP_001165462.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Porphyrin and chlorophyll metabolism - Homo sapiens (human)
- Porphyrin metabolism
Biological Process
- animal organ morphogenesis
- cytochrome c-heme linkage
- oxidation-reduction process
Molecular Function
- holocytochrome-c synthase activity
- metal ion binding
Cellular Component
- mitochondrion
- mitochondrial inner membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000321143
- Coding exons
- 6
- Length
- 11778
- Individuals with no LoFs
- 125642
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 125643
- p
- 0.00000398
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.20 | 75 | 110 | 0.680 | 0.00000875 | 1751 |
| Missense (PolyPhen) | 14 | 44.892 | 0.31186 | 727 | ||
| Synonymous | 0.533 | 37 | 41.4 | 0.895 | 0.00000357 | 488 |
| Loss of Function | 2.86 | 1 | 11.5 | 0.0873 | 8.94e-7 | 185 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000063 | 0.000046 | rare |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Links covalently the heme group to the apoprotein of cytochrome c. {ECO:0000250}.;
- Disease
- DISEASE: Linear skin defects with multiple congenital anomalies 1 (LSDMCA1) [MIM:309801]: A disorder characterized by dermal, ocular, neurological and cardiac abnormalities. LSDMCA1 main features are unilateral or bilateral microphthalmia, linear skin defects in affected females, and in utero lethality for males. Skin defects are limited to the face and neck, consisting of areas of aplastic skin that heal with age to form hyperpigmented areas. Additional features in female patients include agenesis of the corpus callosum, sclerocornea, chorioretinal abnormalities, infantile seizures, congenital heart defect, mental retardation, and diaphragmatic hernia. Microphthalmia is a disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues (anophthalmia). In many cases, microphthalmia/anophthalmia occurs in association with syndromes that include non-ocular abnormalities. {ECO:0000269|PubMed:17033964}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.194
Intolerance Scores
- RVIS EVS
- 0.33
- RVIS percentile EVS
- 73.11
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 0.944
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |